TG and Alpha-thalassemia - X-linked intellectual disability syndrome: In addition to the potential benefits of thyroid hormone treatment, adjusting glial cell-fate imbalances and overcoming intrinsic defects in oligodendroglial cell maturation and the ensuing developmental dysmyelination could be important therapeutic targets to improve white matter defects in ATR-X syndrome patients.